Efficacy and Safety of TenoMiR in Lateral Epicondylitis

Inclusion Criteria:

Subjects must meet all of the following inclusion criteria.

1. Subject has a clinical diagnosis of lateral epicondylitis.

2. Aside from lateral epicondylitis, the subject is otherwise healthy as determined bya responsible physician, based on medical history, physical examinations,concomitant medication, vital signs, 12-lead ECGs and clinical laboratoryevaluations. Laboratory values may be retested once at the discretion of theInvestigator.

3. Subject's symptoms can be reproduced with resisted supination or wrist dorsiflexion (as confirmed by tenderness at lateral epicondyle and positive pick up back of chairsign).

4. Subject's symptoms have persisted for at least 6 weeks to 9 months, despiteconservative treatment that includes 1 or combinations of:

5. Physical therapy

6. Splinting

7. NSAIDs

Exclusion Criteria:

Subjects with any of the following will be excluded from study participation:

1. Subject has undergone previous corticosteroid injection therapy to the affectedelbow in less than 6 months prior to enrolment.

2. Subjects unwilling or unable to discontinue use of pain medication (opiate or NSAID)from at least 1 week prior to Investigational Medicinal Product (IMP)administration.

3. Subject has received previous Platelet-Rich Plasma (PRP) injection to the affectedelbow.

4. Subject uses or has recent use of medications known to affect the skeleton (e.g.,glucocorticoid usage >5 mg/day, fluoroquinolone antibiotics).

5. Subject has undergone surgical intervention to the affected elbow for the treatmentof lateral epicondylitis.